36.07
price down icon1.02%   -0.37
 
loading
Lazard Inc stock is traded at $36.07, with a volume of 1.21M. It is down -1.02% in the last 24 hours and down -16.02% over the past month. Lazard Inc is a financial advisory and asset management firm with operations in North and South America, Europe, the Middle East, Asia, and Australia. Lazard provides advice on mergers and acquisitions, capital markets and capital solutions, restructuring and liability management, geopolitics, and other strategic matters, as well as asset management and investment solutions to institutions, corporations, governments, partnerships, family offices, and high net worth individuals. Geographically, the company earns key revenue in the Americas, EMEA then Asia-Pacific.
See More
Previous Close:
$36.44
Open:
$36.83
24h Volume:
1.21M
Relative Volume:
0.72
Market Cap:
$3.52B
Revenue:
$3.32B
Net Income/Loss:
$282.15M
P/E Ratio:
14.28
EPS:
2.526
Net Cash Flow:
$534.39M
1W Performance:
-1.77%
1M Performance:
-16.02%
6M Performance:
-13.04%
1Y Performance:
-30.98%
1-Day Range:
Value
$35.98
$37.50
1-Week Range:
Value
$35.28
$37.50
52-Week Range:
Value
$35.16
$58.75

Lazard Inc Stock (LAZ) Company Profile

Name
Name
Lazard Inc
Name
Phone
(212) 632-6000
Name
Address
30 ROCKEFELLER PLAZA, NEW YORK
Name
Employee
3,309
Name
Twitter
@lazard
Name
Next Earnings Date
2026-10-22
Name
Latest SEC Filings
Name
LAZ's Discussions on Twitter

Compare LAZ vs MS, GS, SCHW, HOOD, IBKR

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
LAZ icon
LAZ
Lazard Inc
36.07 3.58B 3.32B 282.15M 534.39M 2.526
MS icon
MS
Morgan Stanley
190.31 295.28B 128.77B 20.37B 39.02B 12.37
GS icon
GS
Goldman Sachs Group Inc
902.56 261.08B 128.57B 20.97B 112.72B 64.79
SCHW icon
SCHW
Charles Schwab Corp
96.70 167.23B 28.33B 9.42B 9.76B 5.0426
HOOD icon
HOOD
Robinhood Markets Inc
112.74 107.35B 4.65B 1.89B -2.09B 2.0676
IBKR icon
IBKR
Interactive Brokers Group Inc
88.30 40.43B 10.76B 4.56B 35.82B 2.326

Lazard Inc Stock (LAZ) Upgrades & Downgrades

Date Action Analyst Rating Change
Apr-08-26 Downgrade Keefe Bruyette Outperform → Mkt Perform
Jan-26-26 Initiated BofA Securities Buy
Dec-11-25 Resumed UBS Neutral
Oct-03-25 Initiated BMO Capital Markets Market Perform
Aug-25-25 Upgrade Keefe Bruyette Mkt Perform → Outperform
Apr-07-25 Downgrade Morgan Stanley Equal-Weight → Underweight
Jan-03-25 Downgrade Wolfe Research Outperform → Peer Perform
Dec-20-24 Downgrade Keefe Bruyette Outperform → Mkt Perform
Dec-09-24 Downgrade Morgan Stanley Overweight → Equal-Weight
Sep-12-24 Initiated Wells Fargo Equal Weight
Jan-29-24 Resumed Keefe Bruyette Outperform
Jan-03-24 Upgrade Wolfe Research Peer Perform → Outperform
Sep-19-23 Downgrade Goldman Neutral → Sell
Jul-13-23 Upgrade Keefe Bruyette Underperform → Mkt Perform
Jul-12-23 Upgrade Morgan Stanley Equal-Weight → Overweight
Jul-03-23 Upgrade Wolfe Research Underperform → Peer Perform
Apr-12-23 Upgrade Morgan Stanley Underweight → Equal-Weight
Jul-18-22 Downgrade Morgan Stanley Equal-Weight → Underweight
Jul-13-22 Downgrade Keefe Bruyette Mkt Perform → Underperform
Apr-07-22 Downgrade Wolfe Research Peer Perform → Underperform
Mar-08-22 Downgrade Morgan Stanley Overweight → Equal-Weight
Feb-04-22 Downgrade Keefe Bruyette Outperform → Mkt Perform
Oct-01-21 Upgrade Keefe Bruyette Mkt Perform → Outperform
Apr-07-21 Upgrade Morgan Stanley Equal-Weight → Overweight
Jan-14-21 Downgrade Keefe Bruyette Outperform → Mkt Perform
Dec-16-20 Initiated Seaport Global Securities Buy
Dec-14-20 Upgrade Morgan Stanley Underweight → Equal-Weight
Oct-02-20 Upgrade Wolfe Research Underperform → Peer Perform
Jun-23-20 Initiated Credit Suisse Neutral
Apr-24-20 Downgrade CFRA Hold → Sell
Mar-25-20 Downgrade Wolfe Research Peer Perform → Underperform
Jan-27-20 Upgrade Keefe Bruyette Mkt Perform → Outperform
Jan-06-20 Upgrade Wolfe Research Underperform → Peer Perform
Nov-20-19 Initiated Morgan Stanley Underweight
Jun-10-19 Downgrade UBS Buy → Neutral
Apr-11-19 Downgrade BofA/Merrill Buy → Neutral
Jan-04-19 Resumed Keefe Bruyette Mkt Perform
Nov-06-18 Initiated Goldman Neutral
Apr-17-18 Upgrade BofA/Merrill Neutral → Buy
Jan-03-18 Upgrade Nomura Neutral → Buy
Dec-21-17 Downgrade Buckingham Research Buy → Neutral
Mar-23-17 Upgrade BofA/Merrill Underperform → Neutral
Feb-17-17 Initiated Keefe Bruyette Outperform
Feb-03-17 Reiterated UBS Buy
Jan-20-17 Downgrade Raymond James Strong Buy → Outperform
View All

Lazard Inc Stock (LAZ) Latest News

pulisher
Oct 01, 2026

LAZ Maintained by Goldman Sachs -- Price Target Lowered to $36 - GuruFocus

Oct 01, 2026
pulisher
Oct 01, 2026

An 8 a.m. call will cover Lazard's third-quarter and nine-month results Oct. 22. - Stock Titan

Oct 01, 2026
pulisher
Oct 01, 2026

Lazard to Announce Third Quarter and Nine Month 2026 Financial Results - TradingView

Oct 01, 2026
pulisher
Oct 01, 2026

2053069.IR Interactive Stock Chart | LAZARD EMRG INC-A2 Stock - Yahoo! Finance Canada

Oct 01, 2026
pulisher
Sep 30, 2026

Lazard (NYSE:LAZ) Stock Rating Raised to Hold at Zacks Research - MarketBeat

Sep 30, 2026
pulisher
Sep 30, 2026

US Cost for Gas Power at 17-Year High and Climbing, Lazard Says - EnergyNow.com

Sep 30, 2026
pulisher
Sep 30, 2026

Lazard Ltd (LAZ) stock price, news, quote and history - uk.finance.yahoo.com

Sep 30, 2026
pulisher
Sep 30, 2026

Lazard, Inc. (LAZ) Stock Price, News, Quote & History - Yahoo! Finance Canada

Sep 30, 2026
pulisher
Sep 29, 2026

Zacks Investment Research - גלובס

Sep 29, 2026
pulisher
Sep 29, 2026

Franklin vs. Lazard: Which Stock Has Better Growth Prospects? - Yahoo Finance

Sep 29, 2026
pulisher
Sep 29, 2026

Lazard : Mark Hoban Joins Lazard as Managing Director in the Financial Sponsors Group - marketscreener.com

Sep 29, 2026
pulisher
Sep 28, 2026

Lazard Inc. (LAZ) Slides 2.78% to $35.70 as Shares Retreat Toward SupportNegative Gamma - siam.in

Sep 28, 2026
pulisher
Sep 28, 2026

Lazard, Inc. Announces Appointment of Pranjal Gambhir as Head of Medical Technology - marketscreener.com

Sep 28, 2026
pulisher
Sep 28, 2026

Lazard appoints Pranjal Gambhir as Head of Medi... - Pluang

Sep 28, 2026
pulisher
Sep 28, 2026

Lazard : Pranjal Gambhir Joins Lazard as Head of Medical Technology - marketscreener.com

Sep 28, 2026
pulisher
Sep 28, 2026

After 20 years at Citi, Pranjal Gambhir joins Lazard to lead medical technology coverage. - Stock Titan

Sep 28, 2026
pulisher
Sep 25, 2026

Lazard, Inc. (LAZ) stock price, news, quote and history - sg.finance.yahoo.com

Sep 25, 2026
pulisher
Sep 25, 2026

Lazard stock falls 1.90 percent near its yearly low - AD HOC NEWS

Sep 25, 2026
pulisher
Sep 24, 2026

TPG, StepStone Group, Ridgepost Capital, Perella Weinberg, and Lazard Shares Are Falling, What You Need To Know - Yahoo Finance

Sep 24, 2026
pulisher
Sep 24, 2026

Lazard Global Equity Income A Inc (0P00009WVG.L) Stock Forum & Discussion - Yahoo! Finance Canada

Sep 24, 2026
pulisher
Sep 22, 2026

ETFs Investing in Lazard Inc Stocks - TradingView

Sep 22, 2026
pulisher
Sep 22, 2026

43% of a Lazard fund's payout is estimated to be return of capital - Stock Titan

Sep 22, 2026
pulisher
Sep 22, 2026

Lazard: High-Dividend Yield Is Offset By M&A Weakness (NYSE:LAZ) - Seeking Alpha

Sep 22, 2026
pulisher
Sep 22, 2026

Bank of America Corp DE Acquires New Stake in Lazard, Inc. $LAZ - MarketBeat

Sep 22, 2026
pulisher
Sep 22, 2026

Lazard Global Total Return and Income Fund Declares Monthly Distribution and Issues Estimated Sources of the Distribution Announced in August - PR Newswire

Sep 22, 2026
pulisher
Sep 21, 2026

Lazard Names Matt Spence Head of Defense and Emerging Technology - citybiz

Sep 21, 2026
pulisher
Sep 21, 2026

Lazard (NYSE:LAZ) Reaches New 52-Week LowHere's What Happened - MarketBeat

Sep 21, 2026
pulisher
Sep 21, 2026

Lazard Stock Slides 21% Over 9 Straight Down Days - finance.yahoo.com

Sep 21, 2026
pulisher
Sep 21, 2026

Lazard hires Matt Spence for defense tech banking role - Investing.com

Sep 21, 2026
pulisher
Sep 21, 2026

After 7 years in U.S. security roles, Matt Spence joins Lazard - Stock Titan

Sep 21, 2026
pulisher
Sep 18, 2026

Lazard Stock Slides 20% Over 8 Straight Down Days - Yahoo Finance

Sep 18, 2026
pulisher
Sep 18, 2026

Lazard Stock Slides 20% With A 8-Day Losing Spree - Trefis

Sep 18, 2026
pulisher
Sep 17, 2026

Lazard (LAZ) Slid on Slower M&A Activity - Yahoo Finance

Sep 17, 2026
pulisher
Sep 16, 2026

Lazard Inc (LAZ) Stock Down 5.2% -- Now Undervalued? GF Score: 8 - GuruFocus

Sep 16, 2026
pulisher
Sep 16, 2026

Amundi Cuts Stock Holdings in Lazard, Inc. $LAZ - MarketBeat

Sep 16, 2026
pulisher
Sep 15, 2026

Lazard (LAZ) Stock Could Be 47% Undervalued On Fair Value - Yahoo Finance

Sep 15, 2026
pulisher
Sep 15, 2026

Lazard, Perella Weinberg, Shift4, StoneX, and Atlanticus Holdings Shares Are Falling, What You Need To Know - Yahoo Finance

Sep 15, 2026
pulisher
Sep 15, 2026

Lazard, Inc. Common Stock (NY: LAZ - The Chronicle-Journal

Sep 15, 2026
pulisher
Sep 14, 2026

Lazard's August AUM Rises 1.2% Sequentially: Is Growth Set to Continue? - es.tradingview.com

Sep 14, 2026
pulisher
Sep 14, 2026

Lazard, Inc. (NYSE:LAZ) Receives Consensus Rating of "Hold" from Brokerages - MarketBeat

Sep 14, 2026
pulisher
Sep 13, 2026

Engineers Gate Manager LP Purchases 40,846 Shares of Lazard, Inc. $LAZ - MarketBeat

Sep 13, 2026
pulisher
Sep 11, 2026

Lazard reports assets under management of $290.3 billion By Investing.com - Investing.com Australia

Sep 11, 2026
pulisher
Sep 11, 2026

Lazard reports assets under management of $290.3 billion - investing.com

Sep 11, 2026
pulisher
Sep 11, 2026

Lazard Assets Under Management Rose to $290.3 Billion in August on Market, FX Gains - marketscreener.com

Sep 11, 2026
pulisher
Sep 11, 2026

Lazard's assets under management reach $290.3B in August, boosted by market and FX gains. - Pluang

Sep 11, 2026

Lazard Inc Stock (LAZ) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$41.76
price up icon 2.73%
$81.25
price down icon 2.00%
TW TW
$102.22
price down icon 1.05%
$316.44
price up icon 1.37%
NMR NMR
$9.73
price down icon 0.10%
$88.30
price up icon 2.90%
Cap:     |  Volume (24h):